Prostate cancer in men under 50: the impact of race/ethnicity and family history

Abstract Background Prostate cancer remains a significant global public health concern. It is the most common cancer and the second leading cause of cancer death among men in the United States. Current guidelines offer varying recommendations on prostate cancer screening, and most are focused on men aged 50–69. In this study, we examined key risk factors for prostate cancer in men under 50, emphasizing race/ethnicity and family history to better understand the distribution of higher-grade disease in this younger population. Methods This retrospective analysis utilized data from our hospital’s prostate cancer screening program collected between 2014 and 2024. In our cohort, a total of 312 men under 50 years of age underwent prostate biopsy. We assessed the association of Gleason scores, race/ethnicity, family history, and PSA levels using descriptive statistics analyses. Results Among 312 participants, the largest subgroup was White or Caucasian (n = 202, 64.7%), followed by Black or African American (n = 47, 15.1%), Hispanic or Latino (n = 46, 14.7%), and Asian or Pacific Islander (n = 17, 5.5%). Black or African American men showed a higher proportion of Gleason 7 and above compared with other racial/ethnic groups. A positive first-degree family history was also more frequent among Black or African American men and was correlated with elevated Gleason scores and elevated PSA levels in multiple racial/ethnic categories. Conclusion In our cohort of men under 50, both race/ethnicity and a positive family history are closely associated with higher-grade prostate cancer. These findings suggest that younger men from high-risk backgrounds may benefit from early detection strategies.

• Publication year

  2025

• Venue

  Annals medicus

• Publication date

  2025-07-21

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1080/07853890.2025.2536202PMID 40689716PMCID 12281641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate Cancer Mortality in Men Aged 70 Years Who Recently Underwent Prostate-Specific Antigen Screening

  2025cited by this paper
• Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.

  2024cited by this paper
• Prostate Cancer Screening in Young Men

  2024cited by this paper
• Cancer statistics, 2024

  2024cited by this paper
• The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men

  2024cited by this paper
• A west African ancestry‐associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening

  2024cited by this paper
• EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

  2024cited by this paper
• A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.

  2023cited by this paper
• Prostate Cancer Screening in African American Men: A Review of the Evidence.

  2023cited by this paper
• Genetic predisposition to prostate cancer: an update

  2021cited by this paper
• Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

  2019cited by this paper
• Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement

  2018cited by this paper
• Prostate cancer in young men: an important clinical entity

  2014cited by this paper
• Prevention and early detection of prostate cancer.

  2014cited by this paper
• Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.

  2013cited by this paper
• Predictors of Gleason score upgrading in a large African-American population

  2013cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2009cited by this paper
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.

  2005cited by this paper
• Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

  1994cited by this paper

• No citing papers are available for this paper.